NCT04830046View on ClinicalTrials.gov

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

CompletedOBSERVATIONAL

Enrollment

141

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

September 14, 2021

Study Completion Date

September 14, 2022

Conditions

Multiple MyelomaWaldenstrom MacroglobulinemiaImmune System DisorderCovid19

Trial Locations (2)

02215

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER